Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.720
+0.040 (1.09%)
Nov 22, 2024, 4:00 PM EST - Market closed

Mereo BioPharma Group Statistics

Total Valuation

MREO has a market cap or net worth of $576.22 million. The enterprise value is $502.38 million.

Market Cap 576.22M
Enterprise Value 502.38M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

MREO has 154.90 million shares outstanding. The number of shares has increased by 12.33% in one year.

Current Share Class n/a
Shares Outstanding 154.90M
Shares Change (YoY) +12.33%
Shares Change (QoQ) +8.20%
Owned by Insiders (%) 3.27%
Owned by Institutions (%) 41.05%
Float 100.16M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 7.92
P/TBV Ratio 8.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 502.38
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.09.

Current Ratio 6.10
Quick Ratio 5.83
Debt / Equity 0.09
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -28.24

Financial Efficiency

Return on equity (ROE) is -62.11% and return on invested capital (ROIC) is -28.94%.

Return on Equity (ROE) -62.11%
Return on Assets (ROA) n/a
Return on Capital (ROIC) -28.94%
Revenue Per Employee $30,303
Profits Per Employee -$1.37M
Employee Count 33
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -532,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +63.16% in the last 52 weeks. The beta is 0.97, so MREO's price volatility has been similar to the market average.

Beta (5Y) 0.97
52-Week Price Change +63.16%
50-Day Moving Average 4.15
200-Day Moving Average 3.75
Relative Strength Index (RSI) 41.37
Average Volume (20 Days) 818,621

Short Selling Information

Short Interest 4.57M
Short Previous Month 5.16M
Short % of Shares Out 3.98%
Short % of Float n/a
Short Ratio (days to cover) 6.58

Income Statement

In the last 12 months, MREO had revenue of $1.00 million and -$45.32 million in losses. Loss per share was -$0.31.

Revenue 1.00M
Gross Profit 1.27M
Operating Income -38.07M
Pretax Income n/a
Net Income -45.32M
EBITDA -37.48M
EBIT -38.07M
Loss Per Share -$0.31
Full Income Statement

Balance Sheet

The company has $80.52 million in cash and $6.68 million in debt, giving a net cash position of $73.84 million or $0.48 per share.

Cash & Cash Equivalents 80.52M
Total Debt 6.68M
Net Cash 73.84M
Net Cash Per Share $0.48
Equity (Book Value) 72.54M
Book Value Per Share 0.47
Working Capital 72.52M
Full Balance Sheet

Cash Flow

Operating Cash Flow -30.20M
Capital Expenditures n/a
Free Cash Flow -30.20M
FCF Per Share -$0.19
Full Cash Flow Statement

Margins

Gross Margin 127.30%
Operating Margin -3,806.60%
Pretax Margin -4,584.80%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MREO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.33%
Shareholder Yield -12.33%
Earnings Yield -7.86%
FCF Yield -5.24%

Analyst Forecast

The average price target for MREO is $7.50, which is 101.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.50
Price Target Difference 101.61%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 60.72%
EPS Growth Forecast (5Y) -31.98%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MREO has an Altman Z-Score of 9.32 and a Piotroski F-Score of 2.

Altman Z-Score 9.32
Piotroski F-Score 2